Cases of severe Clostridium difficile colitis proceeding with symptoms of peritonitis
Abstract
Recently there was an increase of Clostridium difficile infection cases with the development of severe pseudomembranous colitis with high mortality and high percentage of backsets. Major reason for this growing problem is the emergence of newer, more virulent and more antibiotic-resistant strains including PCR ribotype 027. The major risk factors for pseudomembranous colitis are hospitalizing, antibiotics exposure, chemotherapy, use of proton-pumps inhibitors, older age, concomitant diseases. The appearance of diarrhea, acute abdominal pain, leukocytosis, hypoproteinemia after antibiotic therapy should be considered as a basis for targeted diagnostics of pseudomembranous colitis with the use of laboratory tests. Fulminant pseudomembranous colitis occurs in 5 % of patient with Clostridium difficile infection. This patients often have severe abdominal pain and can have signs of peritonitis and a markedly increased white blood cells. Colectomy should be considered in patients with fulminant colitis. The mortality rate in fulminant pseudomembranous colitis is up to 70 %. The basis for the prevention of pseudomembranous colitis is a rational prescription of antibacterial agents.
About the Author
E. I. Belinskaya
Irkutsk Municipal Clinical Hospital N 1; Irkutsk State Medical University; Russia Saint Petersburg State University
Russian Federation
Russian Federation
References
1. Дорофеев А.Э., Дядык Е.А., Рассохина О.А. Псевдомембранозный колит: этиопатогенез, клиника, диагностика, лечение // Гастроэнтерология. - 2011. -№ 375. - С. 5-8.
2. Кветная А.С., Макриди П.С., Бехтерева М.К. Современное состояние лабораторной диагностики Clostridium difficile-ассоциированной инфекции // Журнал инфектологии. - 2013. - Т. 5, № 3. - С. 5-12.
3. Немцов Л.М. Псевдомембранозный колит как мультидисциплинарная проблема // Вестник ВГМУ. -2014. - Т. 13, № 3. - С. 6-19. Nemtsov L.M. (2014).
4. Соловей Н.В., Карпов И.А., Глаз О.Ч. C. difficile как основной возбудитель антибиотик-ассоцииро-ванных диарей: современное состояние проблемы // Клиническая инфектология и паразитология. Приложение. - 2013. - С. 102-125.
5. Шептулин А.А. Рефрактерные и рецидивирующие формы колита, ассоциированного с Clostridium difficile // Российский журнал гастроэнтерологии, гепатологии и колопроктологии. - 2011. - Т. 2. -С. 50-53.
6. Bauer M.P., Hensgens P.M., Miller M.A. et al. (2012). Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis. Clinical Infectious Diseases, 55 (2), 149-153.
7. Burke K.E., Lamont J.T. (2014). Clostridium difficile infection: a worldwide disease. Gut and Liver, 8 (1), 1-6.
8. Debast S.B., Bauer M.P., Kuijper E.J. (2014). European society of clinical microbiology and infection disease: update of the treatment guidance document for Clostridium difficile infection. Clinical Microbiology and Infection, 20 (2), 1-26.
9. Girotra M., Kumar V., Khan J.M. et al. (2012). Clinical predictors of fulminant colitis in patient with Clostridium difficile infection. Saudi Journal of Gastroenterology, 18 (2), 133-139.
10. McCollum D.L., Rodriguez J.M. (2012). Detection, treatment and prevention of Clostridium difficile infection. Clinical Gastroenterology and Hepatology, 10, 581-592.
11. Stewart D.B., Hollenbeak C.S., Wilson M.Z. (2013). Is colectomy for fulminant Clostridium difficile colitis life saving? A systematic review. Colorectal Disease, 15, 798-804.
12. Trifan A., Girleanu I., Cojocariu C. et al. (2013). Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication. World Journal of Gastroenterology, 19 (42), 7476-7479.
Review
For citations:
Belinskaya E.I. Cases of severe Clostridium difficile colitis proceeding with symptoms of peritonitis. Acta Biomedica Scientifica. 2015;(4):7-11. (In Russ.)
Views:
580
Email this article 
